Improving healthcare for all

Torksal: the “pioneer” of green nanotechnology

Reduce the side effects of cancer treatments is the challenge Torskal tooks on.

10 Jun 2021

Cancer is one of the leading causes of death worldwide, accounting for nearly 10 million deaths in 2020.

Conventional treatment, such as chemotherapy, remains very harmful, toxic, and mostly poorly targeted as it kills both cancer cells and healthy cells, leading to side effects.

Torskal, a pioneer in innovative green nanotechnology for the treatment of various cancers, proposes an alternate approach.

Torskal has found a unique technique using gold nanoparticles that reduce the side effects by targeting and killing only the cancer cells in a single dose.

This technique has been patented in 40 countries since 2016.

The gold nanoparticles, which are synthesized by green chemistry, are extracted from Hubertia Ambavilla, an endemic plant from the island of Reunion. They are injected into tumor cells to treat skin cancer subcutaneously, such as melanoma. Using a near infrared laser, these gold nanoparticles undergo photothermal heating, resulting in selective hypothermic cell death of adjacent non-tumor tissue.

Torksal was recognized by the 2021 “10,000 startups to change the world” award, by La Tribune, in the “Overseas” category and “Let’s Go France” award by PwC France in 2020, BCG’s strategy award in 2017 and the i-Lab award in the emerging category by Bpifrance in 2015.

Torksal, which is now the “pioneer” of green nanotechnology and aims to become the “leader” in green nanotechnology.

What are you looking for?